In
keeping with the sensitive nature of traded products, marketing is entrusted
to dedicated, highly educated and well-trained associates who offer in-depth
information and constant scientific update to interested parties. Close contact
with key opinion leaders, the organization of lectures and seminars for the
medical community, as well as education of the general public constitute the
core of our sophisticated marketing mix.
Collaborating
with Arriani Pharmaceuticals S.A. offers partners a number of benefits, including;
a. Networking with opinion-leaders internationally
b. Close collaboration with key experts, for the design and implementation
of international product strategy
c. Potential for regulatory support
d. A specialized and dedicated marketing team
Distribution
and active promotion of high-tech and biotechnological drugs testifies to the
company’s unfailing commitment to innovation and aim to actively support public
health. Our portfolio includes ethical products for niche markets – mostly orphan
drugs and drugs for the treatment of life-threatening diseases in the fields
of oncology, rare diseases and haematology. Meant for a select number of patients
and doctors, our high-tech and biotechnological products reflect our core ethical
values.
Orphan drugs and rare diseases
Pharmaceutical products addressed to a small number of patients, thus
usually of no interest to large pharmaceutical companies due to their limited
business interest.
Oncology
Products that aim to confront various forms of cancer and improve
the consequences of the illness, the undesirable effects of the prescribed
treatment and the overall life quality of particular patients.
Haematology
Products related to the aforementioned categories, aiming at restoring the
patients’ hematological system.
